AdvisorShares Trust 13D and 13G filings for Enveric Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 4:12 pm Purchase | 2025-03-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 90,324 3.650% | 87,658 (+3287.97%) | Filing |
| 2025-01-06 5:04 pm Purchase | 2024-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 2,666 5.900% | 1,035 (+63.43%) | Filing |
| 2024-11-12 1:43 pm Purchase | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 1,631 4.110% | 1,114 (+215.62%) | Filing |
| 2023-02-14 5:02 pm Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 517 5.600% | 517 (New Position) | Filing |